Filing Flows › Strive (ASST) › Q3 2026 › vs Q2 2026
Strive (ASST) Q3 2026 vs Q2 2026 (quarter over quarter)
Strive's revenue fell $245K (-8%) from $2.9M in Q2 2026 to $2.7M in Q3 2026. The biggest changes: Medical device revenues −$255K (-18%); Investment advisory fees +$47K (+3%).
Strive, Q3 2026: revenue $2.7M, net earnings $509M, operating cash flow −$10.1M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Investment advisory fees | $1.6M | $1.5M | $47K | +3% |
| Medical device revenues | $1.1M | $1.4M | −$255K | -18% |
| Revenue | $2.7M | $2.9M | −$245K | -8% |
| Other income, net | $1.0M | $646K | $362K | +56% |
| Operating profit | $508M | −$258M | $766M | — |
| Pre-tax earnings | $509M | −$258M | $767M | — |
| Net earnings | $509M | −$258M | $767M | — |
| Operating cash sources | $526M | −$243M | $769M | — |
| Depreciation & amortization | $78K | $86K | −$8K | -9% |
| Share-based compensation | $6.5M | $5.7M | $839K | +15% |
| Cash used in operations | $10.1M | $8.4M | $1.7M | +20% |
| Working capital & other | $526M | −$243M | $769M | — |
Questions
How much did Strive's revenue grow quarter over quarter in Q3 2026?
Strive's revenue fell $245K (-8%) from $2.9M in Q2 2026 to $2.7M in Q3 2026.
What drove Strive's revenue change in Q3 2026?
Medical device revenues −$255K (-18%); Investment advisory fees +$47K (+3%).